Intervention not reported
28‐day all‐cause mortality · hospitalised adults with COVID‐19 (moderate to severe disease)
The intervention probably leads to lower 28‐day all‐cause mortality (moderate certainty).
1 finding from 1 review
- Antiplatelet agents for the treatment of adults with COVID‐19 2023 · Cochrane Headline outcomes onlyRR 0.953 studies · 17249 participantsModerate